|
Volumn 27, Issue 9, 2012, Pages 36-39
|
Biosimilars: An uncertain path to promise: As the costs of drugs rise - Will biosimilars fulfill their promise of affordability?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
BEVACIZUMAB;
BIOSIMILAR AGENT;
ETANERCEPT;
INFLIXIMAB;
INSULIN GLARGINE;
RECOMBINANT ERYTHROPOIETIN;
RITUXIMAB;
TRASTUZUMAB;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ARTICLE;
DRUG COST;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG RESEARCH;
INVESTMENT;
UNITED STATES;
COST;
FOOD AND DRUG ADMINISTRATION;
PATENT;
|
EID: 84867252643
PISSN: 10499156
EISSN: None
Source Type: Trade Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (6)
|